Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient

التفاصيل البيبلوغرافية
العنوان: Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient
المؤلفون: Song Gao, Jiaqian Wang, Zhongzheng Zhu, Juemin Fang, Yu Zhao, Zhuqing Liu, Huanlong Qin, Yuquan Wei, Heng Xu, Xu Dan, Li Yang, Qing Xu
المصدر: Immunotherapy. 15:57-69
بيانات النشر: Future Medicine Ltd, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Oncology, Immunology, Immunology and Allergy
الوصف: Background: Although significant progress has been made in immune checkpoint inhibitor (ICI) treatment of advanced squamous cell carcinoma (SqCC), most patients still experience acquired drug resistance. Methods: We used a dendritic cell-based neoantigen vaccine combined with ICIs to treat advanced SqCC in a PD-1 blockade-resistant patient. Results: The follow-up of this patient after 12 months revealed significant tumor regression. We also identified a new JAK1 ICI-resistant mutation that could become a potential universal neoantigen target for tumor vaccines. Conclusion: Individualized management of advanced SqCC through a combined neoantigen vaccine and ICI administration could yield beneficial clinical outcomes. Vaccines targeting anti-PD-1-resistant JAK1 mutations might be of particular benefit to a specific group of solid tumor patients.
تدمد: 1750-7448
1750-743X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ac09109301641296977131cffb18a367Test
https://doi.org/10.2217/imt-2021-0339Test
رقم الانضمام: edsair.doi...........ac09109301641296977131cffb18a367
قاعدة البيانات: OpenAIRE